Search research articles
Contact Us
Filters
Showing results (471-480 of 596) with videos related to
Page
of 60
Sort By:
Journal of the National Cancer Institute
|
September 22, 2018
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
Joshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2013
Impact of PET staging in limited-stage small-cell lung cancer
Eric P Xanthopoulos, Michael N Corradetti, Nandita Mitra, et al.
The Lancet. Oncology
|
November 13, 2016
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Scott N Gettinger, Lyudmila A Bazhenova, Corey J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407
Steven F Powell, Delvys Rodríguez-Abreu, Corey J Langer, et al.
Clinical Lung Cancer
|
October 9, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
Cole Friedes, Nikhil Yegya-Raman, Siqi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303
Ann Marie Egloff, Ju-Whei Lee, Corey J Langer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 19, 2018
Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion
Charu Aggarwal, Andrew R Haas, Susan Metzger, et al.
JAMA Oncology
|
August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial
Ramesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
Clinical Lung Cancer
|
June 29, 2025
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status
Lyudmila Bazhenova, J G Hodgson, D Ross Camidge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 31, 2016
Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment
Corey J Langer, Coleman Obasaju, Paul Bunn, et al.
Page
of 60
Search research articles
Search
Showing results (471-480 of 596) with videos related to
Sort By:
Page
of 60
Journal of the National Cancer Institute
|
September 22, 2018
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
Joshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2013
Impact of PET staging in limited-stage small-cell lung cancer
Eric P Xanthopoulos, Michael N Corradetti, Nandita Mitra, et al.
The Lancet. Oncology
|
November 13, 2016
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Scott N Gettinger, Lyudmila A Bazhenova, Corey J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407
Steven F Powell, Delvys Rodríguez-Abreu, Corey J Langer, et al.
Clinical Lung Cancer
|
October 9, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
Cole Friedes, Nikhil Yegya-Raman, Siqi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303
Ann Marie Egloff, Ju-Whei Lee, Corey J Langer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 19, 2018
Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion
Charu Aggarwal, Andrew R Haas, Susan Metzger, et al.
JAMA Oncology
|
August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial
Ramesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
Clinical Lung Cancer
|
June 29, 2025
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status
Lyudmila Bazhenova, J G Hodgson, D Ross Camidge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 31, 2016
Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment
Corey J Langer, Coleman Obasaju, Paul Bunn, et al.
Page
of 60